US Patent Litigations are now available. Check here

Explore patent oppositions filed by Boehringer Ingelheim Pharma against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3219328Human Anti-Il-23 Antibodies, Compositions, Method And UsesJANSSEN BIOTECHMar 17, 2021
EP2634243Improved Process For The Culturing Of CellsDPXJun 5, 2018
EP2634242Improved Process For The Culturing Of CellsDPXJan 4, 2018
EP2634250Improved Process For The Culturing Of CellsDPXJan 4, 2018

Explore Boehringer Ingelheim Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP2397142Jul 27, 2022Use Of Dpp Iv Inhibitors5
EP2152341Dec 11, 2019Atomizer, And Filter2
EP2433665Aug 7, 2019Inhaler And Sieve For An Inhaler1
EP1940349Feb 14, 2018Aerosol Formulation For The Inhalation Of Beta Agonists1
EP1830843Nov 7, 2012Indolidone Derivatives For The Treatment Or Prevention Of Fibrotic Diseases2